Neoadjuvant chemotherapy before radical prostatectomy for locally advanced prostate cancer: Protocol for a systematic review and meta-analysis
Conclusion:
The application of taxanes-based chemotherapy has been widened to metastatic hormone sensitive prostate cancer in recent years. To be more vigorous, whether neoadjuvant administration of these cytotoxic agents can improve the outcome of RP in locally advance prostate cancer patients has been explored. This study aims to synthesis data regarding the adverse effect, response rate, recurrence, and survival from multiple trials, and to guide the healthcare practitioners using an evidence-based approach.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Hormones | Internal Medicine | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Prostate Cancer | Prostatectomy | Science | Study